Topiramate Extended-Release Capsules are bioequivalent to the reference listed drug (RLD), Trokendi XR Extended-Release Capsules of Supernus Pharmaceuticals
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals, and commercialization and distribution of Semaglutide across 23 countries globally
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
The EIR was issued following an inspection of the facility from September 8 to September 16, 2025
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
Subscribe To Our Newsletter & Stay Updated
